Watertown, MA, United States of America

Joel Pradines

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joel Pradines: Innovator in Amino Acid Compositions for COVID-19 Treatment.

Introduction

Joel Pradines is an accomplished inventor based in Watertown, MA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of post-acute sequelae of COVID-19. His innovative work focuses on amino acid entities and their therapeutic applications.

Latest Patents

Joel Pradines holds a patent for "Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19." This patent discloses pharmaceutical compositions that comprise amino acid entities and outlines methods for treating individuals suffering from the lingering effects of COVID-19. The compositions are designed to be administered in effective amounts to subjects in need of treatment.

Career Highlights

Throughout his career, Joel has demonstrated a commitment to advancing medical science through his research and inventions. His work has the potential to improve the quality of life for many individuals affected by COVID-19. He is currently associated with Axcella Health Inc., where he continues to innovate and contribute to the field.

Collaborations

Joel Pradines collaborates with talented professionals in his field, including Revati Wani and Alison Schecter. These partnerships enhance the research and development efforts at Axcella Health Inc., fostering an environment of innovation and discovery.

Conclusion

Joel Pradines is a notable inventor whose work in amino acid compositions is paving the way for new treatments for post-acute sequelae of COVID-19. His contributions to the pharmaceutical industry are significant and hold promise for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…